First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial

被引:0
作者
Albiges, L. [1 ]
Tannir, N. M. [2 ]
Burotto, M. [3 ]
McDermott, D. [4 ]
Plimack, E. R. [5 ]
Barthelemy, P. [6 ]
Porta, C. [7 ]
Powles, T. [8 ]
Donskov, F. [9 ]
George, S. [10 ]
Kollmannsberger, C. K. [11 ]
Gurney, H. [12 ,13 ]
Grimm, M. -O. [14 ]
Tomita, Y. [15 ]
Castellano, D. [16 ]
Rini, B. I. [17 ]
Choueiri, T. K. [18 ,19 ]
Leung, D. [20 ]
Saggi, S. S. [21 ]
Lee, C. -W.
McHenry, M. B. [22 ]
Motzer, R. J. [23 ]
机构
[1] Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[3] Bradford Hill Clin Res Ctr, Santiago, Chile
[4] Dana Farber Harvard Canc Ctr, Div Med Oncol, Beth Israel Deaconess Med Ctr, Boston, MA USA
[5] Fox Chase Canc Ctr, Dept Hematol & Oncol, Philadelphia, PA USA
[6] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France
[7] Univ Pavia, Pavia, Italy
[8] Queen Mary Univ London, Barts Canc Inst, Dept Urol, Royal Free NHS Trust, London, England
[9] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[10] Roswell Pk Canc Inst, Dept Med, Buffalo, NY USA
[11] British Columbia Canc Agcy, Dept Med, Vancouver, BC, Canada
[12] Westmead Hosp, Dept Med Oncol, Sydney, NSW, Australia
[13] Macquarie Univ, Sydney, NSW, Australia
[14] Jena Univ Hosp, Dept Urol, Jena, Germany
[15] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan
[16] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain
[17] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN USA
[18] Brigham & Womens Hosp, Dept Med Oncol, Lank Ctr Genitourinary Oncol, Dana Farber Canc Inst, Boston, MA USA
[19] Harvard Med Sch, Boston, MA USA
[20] Bristol Myers Squibb, Dept Imaging, Princeton, NJ USA
[21] Bristol Myers Squibb, Dept Clin Trials, Princeton, NJ USA
[22] Bristol Myers Squibb, Dept Biostat, Princeton, NJ USA
[23] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
关键词
D O I
10.1097/JU.0000000000003058
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:442 / +
页数:3
相关论文
共 5 条
[1]  
Atkinson BJ, J UROLOGY
[2]   Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial [J].
Geynisman, Daniel M. ;
Kadow, Brian T. ;
Shuch, Brian M. ;
Boorjian, Stephen A. ;
Matin, Surena F. ;
Rampersaud, Edward ;
Milestone, Barton N. ;
Plimack, Elizabeth R. ;
Zibelman, Matthew R. ;
Kutikov, Alexander ;
Smaldone, Marc C. ;
Chen, David Y. T. ;
Viterbo, Rosalia ;
Joshi, Shreyas ;
Greenberg, Richard E. ;
Malizzia, Lois ;
McGowan, Thomas ;
Ross, Eric A. ;
Uzzo, Robert G. .
JOURNAL OF UROLOGY, 2020, 204 (03) :531-536
[3]   Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma [J].
Hellenthal, Nicholas J. ;
Underwood, Willie ;
Penetrante, Remedios ;
Litwin, Alan ;
Zhang, Shaozeng ;
Wilding, Gregory E. ;
Teh, Bin T. ;
Kim, Hyung L. .
JOURNAL OF UROLOGY, 2010, 184 (03) :859-864
[4]   The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery [J].
Rini, Brian I. ;
Garcia, Jorge ;
Elson, Paul ;
Wood, Laura ;
Shah, Shetal ;
Stephenson, Andrew ;
Salem, Mohammed ;
Gong, Michael ;
Fergany, Amr ;
Rabets, John ;
Kaouk, Jihad ;
Krishnamurthi, Venkatesh ;
Klein, Eric ;
Dreicer, Robert ;
Campbell, Steven .
JOURNAL OF UROLOGY, 2012, 187 (05) :1548-1554
[5]  
Thomas AA, J UROLOGY